110 related articles for article (PubMed ID: 2747973)
1. [Effects of short-term administration of ibopamine on hemodynamic parameters].
Perroni GB; Longo FN; Anzà V; Girasella R; Macrì I; Urbano O
Minerva Med; 1989 May; 80(5):461-8. PubMed ID: 2747973
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of ibopamine treatment in patients with advanced heart failure: purpose of a new therapeutic scheme with multiple daily administrations.
Dei Cas L; Metra M; Nodari S; Visioli O
J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S111-7. PubMed ID: 2483436
[TBL] [Abstract][Full Text] [Related]
3. Ibopamine vs. digoxin in chronic heart failure: a double-blind, crossover study.
Alicandri C; Fariello R; Boni E; Zaninelli A; Muiesan G
J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S77-82. PubMed ID: 2483444
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the acute hemodynamic effects of ibopamine and dopamine in chronic congestive heart failure.
Sannia L; Ibba GV; Castellaccio M; Dore L
Arzneimittelforschung; 1986 Feb; 36(2A):355-9. PubMed ID: 3707649
[TBL] [Abstract][Full Text] [Related]
5. [Echocardiographic and polygraphic study of acute/effects of Ibopamine on cardiac performance].
Ladelli L; Pezzano A; Sala G; Mangiavacchi M; Cadel A; Brusoni B
G Ital Cardiol; 1983 Oct; 13(10):239-48. PubMed ID: 6667808
[TBL] [Abstract][Full Text] [Related]
6. Influence of ibopamine on heart rate and arrhythmic pattern in patients with congestive heart failure. A double-blind multicentre study.
G Ital Cardiol; 1989 Jan; 19(1):71-80. PubMed ID: 2663585
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamic evaluation during exercise test after acute and chronic ibopamine treatment in patients with congestive heart failure.
Gavazzi A; Mussini A; Bramucci E
Arzneimittelforschung; 1986 Feb; 36(2A):366-70. PubMed ID: 3707652
[TBL] [Abstract][Full Text] [Related]
8. Long-term therapy of chronic congestive heart failure with ibopamine: a multicenter trial.
Rolandi E; Sabino F; Cantoni V; Ghirardi P; Marchetti GV; Cicchetti V
J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S93-103. PubMed ID: 2483446
[TBL] [Abstract][Full Text] [Related]
9. The efficacy of ibopamine in long-term treatment of dilated cardiomyopathy. A clinical and instrumental evaluation.
Benassi A; Modena MG; Mattioli G
Arzneimittelforschung; 1986 Feb; 36(2A):390-4. PubMed ID: 3518726
[TBL] [Abstract][Full Text] [Related]
10. Onset of cardiovascular action after oral ibopamine. Early hemodynamic effects of single and repeated doses in patients with idiopathic dilated myocardiopathy.
Di Mario C; Compostella L; Iavernaro A; Libardoni M; Ghirardi P; Cucchini F
Arzneimittelforschung; 1990 Jun; 40(6):661-6. PubMed ID: 2397001
[TBL] [Abstract][Full Text] [Related]
11. Monitored long-term treatment with ibopamine in patients suffering from severe congestive heart failure.
Avanzini Z; Bellogini GC; Brusoni B; Ciampani N; Dei Cas L; Gazzola U; Maggi GC; Mangiavacchi M; Metra M; Pinca L
Arzneimittelforschung; 1986 Feb; 36(2A):394-7. PubMed ID: 3707656
[TBL] [Abstract][Full Text] [Related]
12. Pharmacotherapeutic profile of ibopamine in heart failure.
Taylor SH
J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S118-23. PubMed ID: 2483437
[TBL] [Abstract][Full Text] [Related]
13. Absence of proarrhythmic effects of ibopamine in patients with congestive heart failure.
Caponnetto S; Terrachini V; Canale C; Bruzzone F; Licciardello L; Marchetti GV
J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S104-10. PubMed ID: 2483435
[TBL] [Abstract][Full Text] [Related]
14. Hemodynamic evaluation of ibopamine in patients with refractory congestive heart failure.
Humar F; Morgera T; Maras P; Camerini F
Arzneimittelforschung; 1986 Feb; 36(2A):360-2. PubMed ID: 3707650
[TBL] [Abstract][Full Text] [Related]
15. [Hemodynamic effects induced by the combined administration of sodium nitroprusside and ibopamine in patients with congestive heart decompensation].
Dei Cas L; Giunti G; Faggiano P; Fappani A; Ferrari R; La Canna G; Riva S; Zanini R
Cardiologia; 1985 Mar; 30(3):205-11. PubMed ID: 4064071
[No Abstract] [Full Text] [Related]
16. The long-term efficacy of ibopamine in treating patients with severe heart failure: a multicenter investigation.
Condorelli M; Bonaduce A; Montemurro A; Mattioli G; Cappello C; Caponnetto S; Terrachini V; Canale C; Varricchio M; Cacciapuoti F
J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S83-92. PubMed ID: 2483445
[TBL] [Abstract][Full Text] [Related]
17. The diisobutyryl ester of N-methyldopamine, ibopamine: evaluation of electrophysiological properties and arrhythmogenicity studies.
Ciampani N; Massacci C; Capestro F; Breccia Fratadocchi G; Mocchegiani R; Ruga O; Purcaro A
Arzneimittelforschung; 1986 Feb; 36(2A):363-6. PubMed ID: 3707651
[TBL] [Abstract][Full Text] [Related]
18. Effects of ibopamine on peripheral hemodynamics: a strain gauge plethysmographic study in patients with congestive heart failure.
Musacci GF; Ansani L; Toselli T; Aggio S; Baracca E; Longhini C
Arzneimittelforschung; 1986 Feb; 36(2A):380-2. PubMed ID: 3707654
[TBL] [Abstract][Full Text] [Related]
19. Effects of ibopamine on systemic, pulmonary and regional hemodynamics. Experimental investigations in anesthetized dogs.
Merlo L; Ghirardi P; Brusoni B; Mussini E; Marchetti G
Arzneimittelforschung; 1986 Feb; 36(2A):304-11. PubMed ID: 3707641
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of acute hemodynamic effects and pharmacokinetic behaviour of ibopamine in patients with severe heart failure.
De Vita C; Triulzi E; Devizzi S; Colombo G; Palvarini M; Pocchiari F; Pataccini R
Arzneimittelforschung; 1986 Feb; 36(2A):349-54. PubMed ID: 3707648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
